Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats. (Q36770743)
Jump to navigation
Jump to search
scientific article published on 14 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats. |
scientific article published on 14 March 2016 |
Statements
Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats (English)
Geraldine Harriman
Jeremy Greenwood
Sathesh Bhat
Xinyi Huang
Ruiying Wang
Debamita Paul
Asish K Saha
William F Westlin
Rosana Kapeller
H James Harwood
2 references
1 reference
1 reference
1 reference
1 reference
1 reference